In conversation with...
A Life Sciences podcast by The Lancet Haematology
0.0 • 0 ratings
Want connect with The Lancet Haematology and email directly about potential partnerships?
Recent Episodes
ASH 2025 Preview - Expert Roundtable
Published: December 2, 2025Arnon Kater and Sabina Kersting on the HOVON 158/NEXT STEP phase 2 trial testing a new first-line treatment regimen for chronic lymphocytic leukaemia
Published: December 1, 2025Ruben Mesa on ropeginterferon alfa-2b for hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia
Published: November 3, 2025A panel of the authors on our Lancet Haematology-Lancet Regional Health Western Pacific Series on mature T-cell and natural killer-cell lymphomas
Published: September 14, 2025Lan-Lan Smith, Cheryl Lai, and Daniela Marín discuss the EHA, ICML, and ISTH conferences
Published: August 4, 2025Paolo Strati on off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma
Published: July 1, 2025A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies
Published: June 13, 2025Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma
Published: April 28, 2025Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia
Published: March 31, 2025Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
Published: March 3, 2025